Skip to content
DraconiticResearch
Search Sources API
197,788 studies31 sourcesUpdated 21 min ago
PreprintCC BY-NCmedRxiv

LynchRisk: a Bayesian network to estimate the probability of Lynch syndrome based on pedigree and tumor characteristics

  1. 1LPSM - Sorbonne Universite

Abstract

BackgroundCurrent Lynch syndrome (LS) prediction models do not account for detailed family structure and tumour mismatch repair (MMR) status. We developed LynchRisk, a Bayesian model that estimates individualized LS probability from pedigree, cancer history and tumour MMR test results.

MethodsLynchRisk combines Mendelian inheritance, age- and sex-specific cancer hazards, affected and unaffected relatives, and detailed MMR status. Parameters were derived from the literature.

ResultsIn two simulated cases of probands with LS-associated cancers, family structure and MMR status markedly changed LS probability estimates, with implications for germline testing decisions. LynchRisk also identified situations in which a negative germline result might be considered sufficient to rule out LS or, conversely, prompt further investigations such as somatic MMR or long-read sequencing.

DiscussionLynchRisk gives individualized LS probability by combining clinical, family, and tumour data at different stages of the diagnostic process. Further work will focus on recalibrating cancer hazard functions, validating model performance through simulations, and developing an R package for use by interested research groups.

Related

  1. Microscopic characteristics of adult dyshormonogenetic goiter: attempt to histologically estimate subtypes
    Mitsuyoshi Hirokawa, Hanna Deguchi-Horiuchi, Shuji Fukata +7
    Endocrine JournalPeer-reviewedCC BY-NC-NDFull textEndocrinology & metabolismJ-STAGE
  2. Hybrid surveillance and Bayesian modelling to estimate brucellosis incidence in a livestock-keeping population in northern Tanzania
    A. L. Holmes, W. A. de Glanville, W. A. Katiti +9
    medRxivPreprintCC BYFull textEpidemiology & public healthmedRxiv
  3. Cognitive Performance and Psychological Characteristics in Patients With Clinically Isolated Syndrome: A Case–Control Study
    Sahar Jamshidi, Nastaran Majdinasab, Ebrahim Behzad +2
    Health science reportsPeer-reviewedCC BY-NCFull textGeneral medicineEurope PMC
  4. Clinical characteristics and treatment analysis of children with glucose transporter type 1 deficiency syndrome: a report of two cases
    Menglu Cao, Bingbing Zhang, Xiao Xiao +2
    Translational pediatricsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Clinical characteristics and preliminary discriminatory value of low triiodothyronine syndrome in patients with peritoneal dialysis-associated peritonitis : A cross-sectional study
    Jiaxin Liu, Liqiang Lv, Junyuan Xiao +3
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@misc{lefebvre2026lynchrisk,
  title = {{LynchRisk: a Bayesian network to estimate the probability of Lynch syndrome based on pedigree and tumor characteristics}},
  author = {A. Lefebvre and P. Benusiglio and G. Nuel},
  howpublished = {medRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.14.26365520},
  url = {https://www.medrxiv.org/content/10.64898/2026.10.14.26365520v1},
  note = {CC BY-NC},
}
RIS
TY  - UNPB
TI  - LynchRisk: a Bayesian network to estimate the probability of Lynch syndrome based on pedigree and tumor characteristics
AU  - A. Lefebvre
AU  - P. Benusiglio
AU  - G. Nuel
PY  - 2026
DA  - 2026/10/14
PB  - medRxiv
DO  - 10.64898/2026.10.14.26365520
UR  - https://www.medrxiv.org/content/10.64898/2026.10.14.26365520v1
AB  - BackgroundCurrent Lynch syndrome (LS) prediction models do not account for detailed family structure and tumour mismatch repair (MMR) status. We developed LynchRisk, a Bayesian model that estimates individualized LS probability from pedigree, cancer history and tumour MMR test results.  MethodsLynchRisk combines Mendelian inheritance, age- and sex-specific cancer hazards, affected and unaffected relatives, and detailed MMR status. Parameters were derived from the literature.  ResultsIn two simulated cases of probands with LS-associated cancers, family structure and MMR status markedly changed LS probability estimates, with implications for germline testing decisions. LynchRisk also identified situations in which a negative germline result might be considered sufficient to rule out LS or, conversely, prompt further investigations such as somatic MMR or long-read sequencing.  DiscussionLynchRisk gives individualized LS probability by combining clinical, family, and tumour data at different stages of the diagnostic process. Further work will focus on recalibrating cancer hazard functions, validating model performance through simulations, and developing an R package for use by interested research groups.
ER  -